Literature DB >> 11874862

Antigen-driven T-cell selection in patients with cervical cancer as evidenced by T-cell receptor analysis and recognition of autologous tumor.

H Pilch1, H Höhn, C Neukirch, K Freitag, P G Knapstein, B Tanner, M J Maeurer.   

Abstract

We characterized the T-cell receptor (TCR) repertoire in freshly harvested tumor lesions, in short-term-expanded CD4(+) tumor infiltrating lymphocytes (TIL) as well as in CD4(+) and CD8(+) peripheral blood lymphocytes (PBL) from three patients with cervical cancer. Skewing of the T-cell repertoire as defined by measuring the length of the complementarity-determining region 3 (CDR3) of the TCR VA and VB chains was observed in CD8(+) PBL, in freshly harvested tumor tissue, as well as in CD4(+) TIL. Comparative analysis of the TCR repertoire revealed unique monoclonal TCR transcripts within the tumor lesion which were not present in PBL, suggesting selection of TCR clonotypes due to antigenic stimulation. TCR repertoire analysis of the short-term (7-day) CD4(+) TIL lines revealed that the TCR composition is markedly different from that in CD4(+) PBL or in the freshly harvested tumor tissue. Only one-third of CD4(+) TIL lines showed HLA-DR-restricted recognition of autologous tumor cells as defined by cytolysis. These data provide support for the antigen-driven selection of T cells within cervical cancer lesions and suggest that analysis of the TCR repertoire may aid in obtaining an objective description of the immune response in patients with cervical cancer who are undergoing epitope-based immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874862      PMCID: PMC119930          DOI: 10.1128/cdli.9.2.267-278.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  35 in total

1.  Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset.

Authors:  M R Rezvany; M Jeddi-Tehrani; A Osterborg; E Kimby; H Wigzell; H Mellstedt
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

2.  Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.

Authors:  M E Ressing; W J van Driel; R M Brandt; G G Kenter; J H de Jong; T Bauknecht; G J Fleuren; P Hoogerhout; R Offringa; A Sette; E Celis; H Grey; B J Trimbos; W M Kast; C J Melief
Journal:  J Immunother       Date:  2000 Mar-Apr       Impact factor: 4.456

3.  CD4+ tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7.

Authors:  H Höhn; H Pilch; S Günzel; C Neukirch; C Hilmes; A Kaufmann; B Seliger; M J Maeurer
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

4.  Frequent contribution of T cell clonotypes with public TCR features to the chronic response against a dominant EBV-derived epitope: application to direct detection of their molecular imprint on the human peripheral T cell repertoire.

Authors:  A Lim; L Trautmann; M A Peyrat; C Couedel; F Davodeau; F Romagné; P Kourilsky; M Bonneville
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

5.  Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy.

Authors:  C Thornburg; D Boczkowski; E Gilboa; S K Nair
Journal:  J Immunother       Date:  2000 Jul-Aug       Impact factor: 4.456

6.  Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia.

Authors:  H J Bontkes; T D de Gruijl; A J van den Muysenberg; R H Verheijen; M J Stukart; C J Meijer; R J Scheper; S N Stacey; M F Duggan-Keen; P L Stern; S Man; L K Borysiewicz; J M Walboomers
Journal:  Int J Cancer       Date:  2000-10-01       Impact factor: 7.396

7.  Human papillomavirus type 33 E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer.

Authors:  H Höhn; H Pilch; S Günzel; C Neukirch; K Freitag; A Necker; M J Maeurer
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Monoclonal TCR mRNA transcripts are preferentially detected in the TCR variable alpha chain in CD8(+) T-lymphocytes: implications for immunomonitoring.

Authors:  H Höhn; T Reichert; C Neukirch; H Pilch; M J Maeurer
Journal:  Int J Mol Med       Date:  1999-02       Impact factor: 4.101

9.  Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.

Authors:  L A Koopman; W E Corver; A R van der Slik; M J Giphart; G J Fleuren
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

10.  MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?

Authors:  W Walter; K Lingnau; E Schmitt; M Loos; M J Maeurer
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

View more
  6 in total

1.  Depressed type 1 cytokine synthesis by superantigen-activated CD4+ T cells of women with human papillomavirus-related high-grade squamous intraepithelial lesions.

Authors:  Bang-Ning Lee; Michele Follen; De-Yu Shen; Anais Malpica; Karen Adler-Storthz; William T Shearer; James M Reuben
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

2.  HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers.

Authors:  Mary L Disis; Yushe Dang; Andrew L Coveler; Edmond Marzbani; Zhong C Kou; Jennifer S Childs; Patricia Fintak; Doreen M Higgins; Jessica Reichow; James Waisman; Lupe G Salazar
Journal:  Cancer Immunol Immunother       Date:  2013-10-26       Impact factor: 6.968

3.  MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy.

Authors:  Georg Dössinger; Mario Bunse; Jeannette Bet; Julia Albrecht; Paulina J Paszkiewicz; Bianca Weißbrich; Isabell Schiedewitz; Lynette Henkel; Matthias Schiemann; Michael Neuenhahn; Wolfgang Uckert; Dirk H Busch
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

4.  Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells.

Authors:  Rachael A Clark; Susan J Huang; George F Murphy; Ilse G Mollet; Dirkjan Hijnen; Manoj Muthukuru; Carl F Schanbacher; Vonetta Edwards; Danielle M Miller; Jenny E Kim; Jo Lambert; Thomas S Kupper
Journal:  J Exp Med       Date:  2008-09-15       Impact factor: 14.307

5.  Proteomic analyser with applications to diagnostics and vaccines.

Authors:  Geoffrey W Hoffmann
Journal:  J Theor Biol       Date:  2004-06-21       Impact factor: 2.691

6.  Next Generation Sequencing-Based Identification of T-Cell Receptors for Immunotherapy Against Hepatocellular Carcinoma.

Authors:  Yipeng Ma; Jiayu Ou; Tong Lin; Lei Chen; Junhui Chen; Mingjun Wang
Journal:  Hepatol Commun       Date:  2021-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.